{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:12:27Z","timestamp":1791022347574,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.pupt.2009.10.007","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T09:15:31Z","timestamp":1256289331000},"page":"121-128","source":"Crossref","is-referenced-by-count":119,"title":["TNF-\u03b1 inhibitors in asthma and COPD: We must not throw the baby out with the bath water"],"prefix":"10.1016","volume":"23","author":[{"given":"Maria Gabriella","family":"Matera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2009.10.007_bib1","first-page":"93","article-title":"Tumor necrosis factors: developments during the last decade","volume":"7","author":"Aggarwal","year":"1996","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.pupt.2009.10.007_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0163-7258(02)00176-6","article-title":"Tumor necrosis factor-\u03b1 in cardiovascular biology and the potential role for anti-tumor necrosis factor-\u03b1 therapy in heart disease","volume":"94","author":"Sack","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2004.09.004","article-title":"TNF-\u03b1, rheumatoid arthritis, and heart failure: a rheumatological dilemma","volume":"4","author":"Sarzi-Puttini","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pupt.2009.10.007_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712598.6.8.797","article-title":"Infliximab for the treatment of psoriasis","volume":"6","author":"Kleyn","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/138955706777698624","article-title":"Biological therapies for inflammatory bowel disease: research drives clinics","volume":"6","author":"Danese","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pupt.2009.10.007_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1389450043345308","article-title":"Cytokines in neuroinflammation and Alzheimer's disease","volume":"5","author":"Cacquevel","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pupt.2009.10.007_bib7","series-title":"Cytokine reference","first-page":"414","article-title":"TNF\u03b1","author":"Aggarwal","year":"2000"},{"key":"10.1016\/j.pupt.2009.10.007_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","article-title":"TNF receptor subtype signalling: differences and cellular consequences","volume":"14","author":"MacEwan","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.pupt.2009.10.007_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/370555a0","article-title":"Processing of tumour necrosis factor-\u03b1 precursor by metalloproteinases","volume":"370","author":"Gearing","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pupt.2009.10.007_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4049\/jimmunol.176.2.721","article-title":"Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation","volume":"176","author":"Smookler","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib11","series-title":"Cytokine reference","first-page":"1620","article-title":"TNF receptors","author":"Aggarwal","year":"2000"},{"key":"10.1016\/j.pupt.2009.10.007_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.95.2.570","article-title":"The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor","volume":"95","author":"Grell","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pupt.2009.10.007_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.cr.7290259","article-title":"Molecular mechanism of TNF signaling and beyond","volume":"15","author":"Liu","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.pupt.2009.10.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.016","article-title":"Positive and negative signaling components involved in TNF\u03b1-induced NF-\u03baB activation","volume":"41","author":"Li","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.pupt.2009.10.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pupt.2009.10.007_bib16","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.4049\/jimmunol.173.7.4500","article-title":"Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28","volume":"173","author":"Kim","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib17","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1073\/pnas.0307347101","article-title":"Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells","volume":"101","author":"Turner","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pupt.2009.10.007_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.176.2.1026","article-title":"TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo","volume":"176","author":"Kim","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib19","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.1074\/jbc.M505291200","article-title":"Tumor necrosis factor (TNF) \u03b1 increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2","volume":"280","author":"Theiss","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pupt.2009.10.007_bib20","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-07-0185","article-title":"Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis","volume":"67","author":"Zhao","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pupt.2009.10.007_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.175.2.323","article-title":"Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors","volume":"175","author":"Aderka","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib22","first-page":"16","article-title":"The role of tumor necrosis factor in health and disease","volume":"57","author":"Beutler","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pupt.2009.10.007_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.pupt.2009.10.007_bib24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1096\/fj.05-5603rev","article-title":"TNF receptor superfamily-induced cell death: redox-dependent execution","volume":"20","author":"Shen","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pupt.2009.10.007_bib25","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood.V94.6.1878","article-title":"Nuclear factor-\u03baB-dependent induction of interleukin-8 gene expression by tumor necrosis factor \u03b1: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation","volume":"94","author":"Vlahopoulos","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.pupt.2009.10.007_bib26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pupt.2009.10.007_bib27","doi-asserted-by":"crossref","first-page":"21128","DOI":"10.1016\/S0021-9258(17)45336-1","article-title":"Cooperative interaction of NF-\u03baB and cis-regulatory enhancer binding protein-like factor binding elements in activating the IL-8 gene by pro-inflammatory cytokines","volume":"265","author":"Mukaida","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pupt.2009.10.007_bib28","doi-asserted-by":"crossref","first-page":"C347","DOI":"10.1152\/ajpcell.00166.2001","article-title":"Differential requirement for NF-\u03baB-inducing kinase in the induction of NF-\u03baB by IL-1\u03b2, TNF-\u03b1, and Fas","volume":"283","author":"Russo","year":"2002","journal-title":"Am J\u00a0Physiol Cell Physiol"},{"key":"10.1016\/j.pupt.2009.10.007_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/01652176.2000.9695016","article-title":"Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review","volume":"22","author":"Witkamp","year":"2000","journal-title":"Vet Q"},{"key":"10.1016\/j.pupt.2009.10.007_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-7-125","article-title":"Role of TNF\u03b1 in pulmonary pathophysiology","volume":"7","author":"Mukhopadhyay","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2009.10.007_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2222.1993.tb00317.x","article-title":"The potential role of tumour necrosis factor \u03b1 in asthma","volume":"23","author":"Kips","year":"1993","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pupt.2009.10.007_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-6749(91)90149-I","article-title":"Increased secretion of tumor necrosis factor \u03b1 and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction","volume":"561","author":"Gosset","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1164\/ajrccm\/146.3.768","article-title":"Tumor necrosis factor \u03b1 and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation","volume":"146","author":"Gosset","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2009.10.007_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm\/147.2.291","article-title":"Elevated release of tumor necrosis factor-\u03b1 and interferon-\u03b3 by bronchoalveolar leukocytes from patients with bronchial asthma","volume":"147","author":"Cembrzynska-Nowak","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2009.10.007_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2222.1991.tb03205.x","article-title":"TNF \u03b1 mRNA expression in allergic inflammation","volume":"21","author":"Ying","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pupt.2009.10.007_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1165\/ajrcmb.10.5.8179909","article-title":"Interleukin-4, -5, and -6 and tumor necrosis factor-\u03b1 in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines","volume":"10","author":"Bradding","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1378\/chest.105.3.687","article-title":"Detection of cytokines and their cellular sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness","volume":"105","author":"Ackerman","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.10.007_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","article-title":"Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD","volume":"155","author":"Keatings","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1081-1206(10)63303-0","article-title":"Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum","volume":"86","author":"Obase","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib40","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI119341","article-title":"Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids","volume":"99","author":"Lilly","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pupt.2009.10.007_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1165\/ajrcmb.13.1.7541219","article-title":"Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro","volume":"13","author":"Harkonen","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1165\/ajrcmb.12.2.7865217","article-title":"Tumor necrosis factor-\u03b1 induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells","volume":"12","author":"Levine","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1165\/ajrcmb\/7.2.214","article-title":"Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil\u2013epithelial cell adhesion","volume":"7","author":"Tosi","year":"1992","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0006-2952(96)00771-X","article-title":"Expression of endothelin-1 in human broncho-epithelial and monocytic cell lines: influence of tumor necrosis factor \u03b1 and dexamethasone","volume":"53","author":"Aubert","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pupt.2009.10.007_bib45","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1165\/ajrcmb.20.5.3463","article-title":"Interleukin-5 production by human airway epithelial cells","volume":"20","author":"Salvi","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib46","doi-asserted-by":"crossref","first-page":"L719","DOI":"10.1152\/ajplung.00406.2002","article-title":"Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts","volume":"285","author":"Richter","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2009.10.007_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/00016480310001268","article-title":"Tumor necrosis factor increases MUC1 mRNA in cultured human nasal epithelial cells","volume":"123","author":"Shirasaki","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.pupt.2009.10.007_bib48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1165\/ajrcmb.13.5.7576687","article-title":"Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase","volume":"13","author":"Adler","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib49","doi-asserted-by":"crossref","first-page":"23243","DOI":"10.1074\/jbc.M300096200","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1 induce MUC5AC overexpression through a mechanism involving ERK\/p38 mitogen-activated protein kinases\u2013MSK1\u2013CREB activation in human airway epithelial cells","volume":"278","author":"Song","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pupt.2009.10.007_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0167-4889(95)00143-3","article-title":"Tumor necrosis factor-\u03b1 induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cells","volume":"1310","author":"Wu","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pupt.2009.10.007_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1165\/ajrcmb\/9.4.455","article-title":"Release of interleukin-8, interleukin-6, and colony stimulating factors by upper airway epithelial cells: implications for cystic fibrosis","volume":"9","author":"Bedard","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib52","first-page":"L238","article-title":"TNF-\u03b1-induced transendothelial neutrophil migration is IL-8 dependent","volume":"266","author":"Smart","year":"1994","journal-title":"Am J Phys"},{"key":"10.1016\/j.pupt.2009.10.007_bib53","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.4049\/jimmunol.152.8.4087","article-title":"Pulmonary epithelial cells facilitate TNF\u03b1-induced neutrophil chemotaxis. A role for cytokine networking","volume":"152","author":"Smart","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1165\/ajrcmb.13.5.7576691","article-title":"Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-\u03b1 and interleukin-1\u03b2","volume":"13","author":"Godding","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1165\/ajrcmb.15.1.8679220","article-title":"TNF \u03b1 is important in human lung allergic reactions","volume":"15","author":"Casale","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1164\/ajrccm.152.1.7599866","article-title":"Tumor necrosis factor-\u03b1 increases airway responsiveness and sputum neutrophilia in normal human subjects","volume":"152","author":"Thomas","year":"1995","journal-title":"Am J\u00a0Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1476-5381.2008.00045.x","article-title":"Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs","volume":"156","author":"Nie","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2009.10.007_bib58","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1164\/ajrccm.158.supplement_2.13tac120","article-title":"Muscarinic receptors and control of airway smooth muscle","volume":"158","author":"Fryer","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10038-006-0007-3","article-title":"An association between asthma and TNF-308G\/A polymorphism: meta-analysis","volume":"51","author":"Aoki","year":"2006","journal-title":"J Hum Genet"},{"key":"10.1016\/j.pupt.2009.10.007_bib60","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.200404-511OC","article-title":"Tumor necrosis factor-\u03b1 drives 70% of cigarette smoke-induced emphysema in the mouse","volume":"170","author":"Churg","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib61","doi-asserted-by":"crossref","first-page":"50s","DOI":"10.1183\/09031936.01.00229701","article-title":"Cytokines in chronic obstructive pulmonary disease","volume":"34","author":"Chung","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.10.007_bib62","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.200410-1349OC","article-title":"Tumour necrosis factor-\u03b1 overexpression in lung disease: a single cause behind a complex phenotype","volume":"171","author":"Lundblad","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib63","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1165\/rcmb.2003-0062OC","article-title":"Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumour necrosis factor-a","volume":"30","author":"Vuillemenot","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2009.10.007_bib64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1015905010086","article-title":"Oxidative stress and TNF-\u03b1 induce histone acetylation and NF-\u03baB\/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation","volume":"234\u2013235","author":"Rahman","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pupt.2009.10.007_bib65","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.177.5.1277","article-title":"Tumor necrosis factor \u03b1 (TNF-\u03b1)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55","volume":"177","author":"Mackay","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib66","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1164\/ajrccm.150.5.7952575","article-title":"Tumor necrosis factor \u03b1 levels and weight loss in chronic obstructive pulmonary disease","volume":"150","author":"Di Francia","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib67","first-page":"146","article-title":"Comparison of inflammatory cytokines in chronic obstructive pulmonary disease, asthma and controls","volume":"7","author":"Keatings","year":"1997","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pupt.2009.10.007_bib68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0954-6111(96)90202-4","article-title":"Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis","volume":"90","author":"Mueller","year":"1996","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.153.2.8564092","article-title":"Differences in interleukin-8 and tumor necrosis factor-\u03b1 in induced sputum from patients with chronic obstructive pulmonary disease or asthma","volume":"153","author":"Keatings","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib70","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1590\/S0100-879X2005000900010","article-title":"Concentration of CCL11, CXCL8 and TNF-\u03b1 in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation","volume":"38","author":"Daldegan","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pupt.2009.10.007_bib71","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.rmed.2005.08.022","article-title":"Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease","volume":"100","author":"Hacievliyagil","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib72","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/ajrccm.153.2.8564110","article-title":"Elevated TNF\u03b1 production by peripheral monocytes of weight losing COPD patients","volume":"153","author":"de Godoy","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/thx.2007.086751","article-title":"Inter-relationships between inflammatory markers in stable COPD patients with bronchitis: the intra- and inter- patient variability","volume":"63","author":"Sapey","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2009.10.007_bib74","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/ajrccm.163.2.2006031","article-title":"Association of tumor necrosis factor \u03b1 gene promoter polymorphism with the presence of chronic obstructive pulmonary disease","volume":"163","author":"Sakao","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib75","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1378\/chest.122.2.416","article-title":"Association of tumor necrosis factor-\u03b1 gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD","volume":"122","author":"Sakao","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.10.007_bib76","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1378\/chest.118.4.971","article-title":"A polymorphism in the tumor necrosis factor-\u03b1 gene promoter region may predispose to a poor prognosis in COPD","volume":"118","author":"Keatings","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2009.10.007_bib77","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2362.1998.00285.x","article-title":"Cellular and molecular characteristics of inflammation in chronic bronchitis","volume":"28","author":"Sun","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pupt.2009.10.007_bib78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/ajrccm.163.2.2003122","article-title":"Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease","volume":"163","author":"Aaron","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib79","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/thx.2005.045260","article-title":"Tumour necrosis factor (TNF\u03b1) as a novel therapeutic target in symptomatic corticosteroid dependent asthma","volume":"60","author":"Howarth","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2009.10.007_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1465-9921-9-47","article-title":"Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study","volume":"9","author":"Hackett","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2009.10.007_bib81","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1529-8019.2007.00138.x","article-title":"TNF-\u03b1 inhibitors","volume":"20","author":"Jackson","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib82","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2036.1999.00027.x","article-title":"Safety of infliximab in clinical trials","volume":"13","author":"Hanauer","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib84","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00945-7","article-title":"Reactivation of histoplasmosis after treatment with infliximab","volume":"112","author":"Nakelchik","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib85","first-page":"33","article-title":"What are the risks of biologic therapy in rheumatoid arthritis? An update on safety","volume":"65","author":"Weisman","year":"2002","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.pupt.2009.10.007_bib86","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI18991","article-title":"TNF-\u03b1 is a critical negative regulator of type 1 immune activation during intracellular bacterial infection","volume":"113","author":"Zganiacz","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pupt.2009.10.007_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.sder.2006.12.002","article-title":"Complications and adverse reactions in the use of newer biologic agents","volume":"26","author":"Callen","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.pupt.2009.10.007_bib88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejheart.2005.01.008","article-title":"Frequent noncardiac comorbidities in patients with chronic heart failure","volume":"7","author":"Dahlstrom","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pupt.2009.10.007_bib89","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pupt.2009.10.007_bib90","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2009.10.007_bib91","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor \u03b1 therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pupt.2009.10.007_bib92","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor \u03b1 in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib93","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.rmed.2005.02.031","article-title":"Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation","volume":"99","author":"Rouhani","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib94","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/thx.2007.086314","article-title":"The role of a soluble TNF\u03b1 receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial","volume":"63","author":"Morjaria","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2009.10.007_bib95","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/rccm.200601-072OC","article-title":"The effects of a monoclonal antibody directed against tumor necrosis factor-\u03b1 in asthma","volume":"174","author":"Erin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib96","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","article-title":"A randomized, double-blind, placebo-controlled study of tumor necrosis factor \u03b1 blockade in severe persistent asthma","volume":"179","author":"Wenzel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib97","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jaci.2008.01.065","article-title":"Pharmacogenetic identification of increased responsiveness in severe asthma with anti-TNF (golimumab) therapy","volume":"121","author":"Meyers","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib98","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.200501-147OC","article-title":"First study of infliximab treatment in patients with chronic obstructive pulmonary disease","volume":"172","author":"van der Vaart","year":"2005","journal-title":"Am J\u00a0Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib99","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1164\/rccm.200607-995OC","article-title":"The safety and efficacy of infliximab in moderate-to-severe chronic obstructive pulmonary disease","volume":"175","author":"Rennard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000117386","article-title":"Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study","volume":"76","author":"Dentener","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2009.10.007_bib101","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pupt.2007.03.003","article-title":"TNF-\u03b1 antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease","volume":"21","author":"Suissa","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib102","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.coph.2007.03.001","article-title":"TNF-\u03b1 in asthma","volume":"7","author":"Berry","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pupt.2009.10.007_bib103","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/rccm.200702-253ED","article-title":"Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease","volume":"175","author":"Barnes","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2009.10.007_bib104","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s10875-009-9286-8","article-title":"Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD","volume":"29","author":"Sapey","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.pupt.2009.10.007_bib105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1081\/COPD-200050680","article-title":"A two stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral and non-infectious origin of COPD exacerbations","volume":"2","author":"Dal Negro","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2009.10.007_bib106","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1183\/09031936.00100307","article-title":"Tumour necrosis factor polymorphisms are associated with COPD","volume":"31","author":"Gingo","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2009.10.007_bib107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1465-9921-9-52","article-title":"The TNF \u03b1 gene relates to clinical phenotype in \u03b1-1-antitrypsin deficiency","volume":"9","author":"Wood","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2009.10.007_bib108","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/429998","article-title":"Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?","volume":"41","author":"Ehlers","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pupt.2009.10.007_bib109","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pupt.2009.10.007_bib110","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2004.01.036","article-title":"Binding activities of infliximab and etanercept to transmembrane tumor necrosis factor-\u03b1","volume":"126","author":"Mitoma","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pupt.2009.10.007_bib111","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","article-title":"Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-\u03b1","volume":"128","author":"Mitoma","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pupt.2009.10.007_bib112","first-page":"118","article-title":"TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis","volume":"22","author":"Gudbrandsdottir","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pupt.2009.10.007_bib113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","article-title":"Biological functions of tumor necrosis factor cytokines and their receptors","volume":"14","author":"Pfeffer","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.pupt.2009.10.007_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-\u03b1 monoclonal antibody cA2 binds recombinant transmembrane TNF-\u03b1 and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.pupt.2009.10.007_bib115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.62.6.561","article-title":"Up regulation of the production of tumour necrosis factor \u03b1 and interferon \u03b3 by T cells in ankylosing spondylitis during treatment with etanercept","volume":"62","author":"Zou","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pupt.2009.10.007_bib116","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","article-title":"Serum cytokines (IL-6, TNF-\u03b1, IL-1\u03b2 and IFN-\u03b3) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity","volume":"33","author":"Gratac\u00f3s","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.pupt.2009.10.007_bib117","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2009.10.007_bib118","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/15412550701629663","article-title":"Phenotypes of chronic obstructive pulmonary disease","volume":"4","author":"Friedlander","year":"2007","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2009.10.007_bib119","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/thx.2007.095042","article-title":"Antagonism of tumour necrosis factor \u03b1 in refractory asthma","volume":"63","author":"Berry","year":"2008","journal-title":"Thorax"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553909001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553909001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T08:17:29Z","timestamp":1685175449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553909001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1094553909001138"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2009.10.007","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}